Product Information
DROSPIRENONE-EE 3-0.03 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1492 per EA under NDC 31722094532. Its NADAC has been published 192 times since Dec 21, 2022.
FDA first approved this application on Jan 24, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722094532
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA213034FDA Approved
1/24/2020
TE Code
AB
On Market Since
1/24/2020
Price Statistics
The NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has been published 192 times since Dec 21, 2022, and over the history we have for it it has declined 24.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1492 per EA |
|---|---|
| All-time high | $0.2062 (Apr 12, 2023) |
| All-time low | $0.1445 (Jul 22, 2026) |
| 52-week high | $0.1731 |
| 52-week low | $0.1445 |
| Median price | $0.1731 |
| Average price | $0.1753 |
| Largest weekly change | +27.6% (Jun 19, 2024) |
| Weeks tracked | 192 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DROSPIRENONE-EE 3-0.03 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DROSPIRENONE-EE 3-0.03 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $0.1492 per EA (NDC 31722094532), effective Aug 19, 2026.
How has the price of DROSPIRENONE-EE 3-0.03 MG TAB changed over time?
Over the history we have for it, the NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has declined 24.8%. It has been tracked across 192 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for DROSPIRENONE-EE 3-0.03 MG TAB?
Since Dec 21, 2022, the NADAC for DROSPIRENONE-EE 3-0.03 MG TAB has ranged from a low of $0.1445 (Jul 22, 2026) to a high of $0.2062 (Apr 12, 2023), with a median of $0.1731 per EA.
Are there cheaper alternatives to DROSPIRENONE-EE 3-0.03 MG TAB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DROSPIRENONE-EE 3-0.03 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DROSPIRENONE-EE 3-0.03 MG TAB?
DROSPIRENONE-EE 3-0.03 MG TAB (NDC 31722094532) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.